Technical breakout gains traction: Social media traders are spotlighting Celestica's decisive break from a lengthy consolidation, backed by rising volume on weekly charts. Many see this as a shift toward leadership alongside semis and datacenter plays. The overall vibe signals mounting optimism.
AI supply chain exposure highlighted: Conversations emphasize partnerships like the AMD Helios rack-scale platform, positioning the firm in high-demand AI infrastructure. Investors group it with peers in optics and electronics manufacturing amid sector strength. Enthusiasm builds on structural margin shifts and capacity expansions.
Earnings watch intensifies: With results slated for April 27 after 17 straight beats, focus sharpens on potential upside from new bases forming near recent highs. Watchlists expand as the stock tests key pivots. Bullish sentiment dominates the discourse.
Note: This discussion summary was generated from an AI condensation of post data.
Celestica Insider Trading Activity
Celestica insiders have traded $CLS stock on the open market 20 times in the past 6 months. Of those trades, 4 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $CLS stock by insiders over the last 6 months:
- JASON PHILLIPS (President) has made 0 purchases and 2 sales selling 120,000 shares for an estimated $36,892,200.
- YANN L ETIENVRE (Chief Operations Officer) has made 0 purchases and 4 sales selling 96,561 shares for an estimated $28,082,037.
- TODD C COOPER (President) has made 0 purchases and 3 sales selling 90,549 shares for an estimated $26,024,113.
- LEILA WONG (Chief Human Resources Officer) has made 0 purchases and 3 sales selling 33,110 shares for an estimated $9,617,636.
- LAURETTE T KOELLNER has made 4 purchases buying 6,000 shares for an estimated $2,050,025 and 0 sales.
- DOUGLAS MICHAEL PARKER (Chief Legal Officer) has made 0 purchases and 4 sales selling 3,672 shares for an estimated $1,052,271.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Celestica Revenue
Celestica had revenues of $3.7B in Q4 2025. This is an increase of 43.57% from the same period in the prior year.
You can track CLS financials on Quiver Quantitative's CLS stock page.
Celestica Congressional Stock Trading
Members of Congress have traded $CLS stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLS stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $100,000 on 11/03, 10/31 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Celestica Hedge Fund Activity
We have seen 387 institutional investors add shares of Celestica stock to their portfolio, and 371 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,657,874 shares (+5806149.2%) to their portfolio in Q4 2025, for an estimated $1,081,304,133
- WHALE ROCK CAPITAL MANAGEMENT LLC removed 1,110,944 shares (-37.1%) from their portfolio in Q4 2025, for an estimated $328,406,155
- FMR LLC removed 1,106,322 shares (-13.0%) from their portfolio in Q4 2025, for an estimated $327,039,846
- AQR CAPITAL MANAGEMENT LLC added 1,066,543 shares (+inf%) to their portfolio in Q4 2025, for an estimated $315,280,776
- VOYA INVESTMENT MANAGEMENT LLC removed 958,577 shares (-40.1%) from their portfolio in Q4 2025, for an estimated $283,364,946
- JPMORGAN CHASE & CO added 803,182 shares (+25.0%) to their portfolio in Q4 2025, for an estimated $237,428,631
- NATIONAL BANK OF CANADA /FI/ added 665,078 shares (+365.3%) to their portfolio in Q4 2025, for an estimated $196,603,707
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Celestica Analyst Ratings
Wall Street analysts have issued reports on $CLS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
- Citigroup issued a "Buy" rating on 11/10/2025
- Goldman Sachs issued a "Buy" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/29/2025
- CIBC issued a "Outperformer" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
To track analyst ratings and price targets for Celestica, check out Quiver Quantitative's $CLS forecast page.
Celestica Price Targets
Multiple analysts have issued price targets for $CLS recently. We have seen 10 analysts offer price targets for $CLS in the last 6 months, with a median target of $360.0.
Here are some recent targets:
- Todd Coupland from CIBC set a target price of $360.0 on 03/11/2026
- George Wang from Barclays set a target price of $391.0 on 01/30/2026
- Atif Malik from Citigroup set a target price of $338.0 on 01/30/2026
- Ruben Roy from Stifel set a target price of $385.0 on 10/29/2025
- David Vogt from UBS set a target price of $350.0 on 10/29/2025
- Michael Ng from Goldman Sachs set a target price of $440.0 on 10/29/2025
- Daniel Chan from TD Securities set a target price of $305.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
